Bacterial lipopeptide (BLP) (BLP)

Bacterial lipopeptides are a diverse class of molecules produced by various bacterial species, consisting of a lipid tail covalently linked to a peptide headgroup. In the context of immunology, they serve as potent pathogen-associated molecular patterns (PAMPs) that are recognized by the host's innate immune system via Toll-like receptor 2 (TLR2) [1]. Recognition typically involves the formation of heterodimers between TLR2 and either TLR1 (for triacylated lipopeptides) or TLR6 (for diacylated lipopeptides), which triggers the MyD88-dependent signaling pathway [2]. This activation leads to the translocation of NF-κB and the subsequent production of pro-inflammatory cytokines such as TNF-α and IL-6 [3]. Beyond their role as immune stimulants, certain bacterial lipopeptides like daptomycin and polymyxins are utilized as essential "last-resort" antibiotics [4]. These therapeutic lipopeptides function by disrupting bacterial cell membrane integrity, leading to ion leakage and rapid cell death [5]. While they are not classical therapeutic targets themselves, their interaction with host receptors is a major focus for developing vaccine adjuvants and anti-inflammatory therapies [6].

Other names

LipopeptidesBacterial lipoproteinsPathogen-associated molecular patternsTLR2 ligandsBLPs

Bacterial lipopeptides act as ligands for Toll-like receptor 2 (TLR2), inducing its heterodimerization with TLR1 or TLR6 to activate the MyD88-dependent pro-inflammatory signaling pathway [1, 2]. In antimicrobial therapy, lipopeptide drugs like daptomycin insert into the bacterial cell membrane in a calcium-dependent manner, causing membrane depolarization and rapid cell death [4, 5].